GenomOncology
About GenomOncology
GenomOncology is a healthcare AI company that provides a precision oncology platform designed to transform complex and fragmented oncology data into actionable intelligence. Their solutions aim to improve cancer care by streamlining workflows for molecular pathologists, oncologists, clinical trial professionals, bioinformaticians, and clinical researchers. The company’s platform offers tools for molecular pathology reporting, clinical trial optimization, and data enablement, leveraging AI, natural language processing (NLP), and a comprehensive knowledge base.
For physicians, GenomOncology’s platform delivers transparent, explainable AI that generates real-time, auto-generated data interpretations at the point of care. This includes integrating all assay and lab data into a single report to increase operational efficiency. The platform also automates and customizes patient treatment with clinical trial matching, helping to accelerate enrollment and expand access to relevant studies. Furthermore, GenomOncology’s solutions seamlessly integrate with existing LIS, LIMS, and EHR systems for automated, bidirectional data exchange, ensuring that oncologists have access to comprehensive patient information for informed decision-making.
The company’s offerings address the growing complexity of precision oncology, where a vast number of FDA indications and active clinical trials can make identifying the “next-best decision” challenging. GenomOncology’s platform is built to unify data, workflows, and insights across cancer care, serving as an embedded intelligence layer within oncology ecosystems. This enables clinicians, labs, and researchers to act faster and with greater clarity, ultimately redefining how institutions deliver personalized care and advancing translational research.
Focus Areas
Business Intelligence
| Technology | cloud-native or on-premise deployment, AI-enabled Precision Oncology Platform (POP), augmented intelligence stack, AI/NLP-powered platform (igniteIQ), knowledge graph, symbolic AI, large language models (LLMs), natural language processing (NLP) |
What Physicians Need to Know
For physicians, GenomOncology's solutions streamline complex genomic data into actionable insights, enabling faster, more confident, and scalable clinical decisions. The platform provides real-time, biomarker-specific clinical trial matching, integrating directly into existing workflows to reduce administrative burden and accelerate patient enrollment. The Pathology Workbench simplifies NGS reporting, offering comprehensive variant analysis and customizable reports that can be delivered directly to the EHR. The transparent and explainable AI delivers real-time, auto-generated data interpretations for every case, fostering trust and clarity in decision-making. Furthermore, the integration of prior treatment eligibility criteria refines treatment matching, providing more clinically relevant options based on a patient's complete history.
GenomOncology offers seamless integration with existing systems through its GO API Suite, enabling bidirectional data flow with any LIS, EHR (e.g., Epic, Meditech, Cerner), or LIMS, on any infrastructure, using standards-based HL7, FHIR, and REST connectivity. The platform supports both cloud-ready and on-premise deployment options, offering flexibility and data sovereignty. They also partner with other genomic intelligence companies like Genomenon to enhance germline variant classification and genomic reporting.
Videos
News, demos, and interviews about GenomOncology.
Videos load interactively. If none appear, search YouTube for GenomOncology →
Frequently Asked Questions
Related Companies
A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]
OpenAI is an American artificial intelligence (AI) company that conducts research and develops advanced AI models. While widely known for its generative AI models like ChatGPT and DALL-E, OpenAI has significantly expanded its focus into the healthcare sector. The company’s mission is to ensure that artificial general intelligence (AGI) benefits all of humanity, and this […]
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]
The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]